The measurement of MHC-presented peptides is currently considered a highly impactful method within the recent surge of interest in vaccine development due to the SARS-CoV-2 pandemic [7,8] and to increasing development of antimicrobial resistance (AMR) [9,10,11], as well as the further emerging interest in effective and well-tolerated cancer immune therapy [12,13]. This evidence concerns the gene HLA-C and cancer.